Terrence M. Kungel
Trustee Emeritus
Terry Kungel is a 1969 initiate of the Purdue University Circle of Omicron Delta Kappa. He served as president of the circle as an undergraduate. He was a trustee of the O∆K Foundation Board of Trustees from 2014-18 and is former chair of its Investment Committee. Terry was designated as an emeritus trustee in July 2022.
Terry is Chairman and Chief Executive Officer Emeritus of the Maine Coalition to Fight Prostate Cancer. He is the third generation of his family to suffer from this disease. He withdrew from MCFPC after 10 years when he was diagnosed with colon cancer and had to undergo treatment. As CEO, Terry assisted six prostate cancer network groups serving 250-500 active prostate cancer patients and their loved ones and more than 10,000 inactive prostate cancer patients in Maine. This organization promotes awareness, outreach, education, fund-raising and patient assistance. He represents Maine as a Consumer Reviewer, Congressionally Directed Medical Research Program, which helps identify research grants that merit funding by the Prostate Cancer Research Program, Department of Defense. He serves as a Patient Representative, Advisory Committee Member, Special Government Employee, Food and Drug Administration. And he serves as a Patient PCORI Merit Reviewer and PCORI Ambassador for the Patient Centered Outcomes Research Institute.
Terry was the co-founder and CEO of a biotech company that utilized 10,000+ DNA samples to identify disease associated genes. The company was the discoverer of record for 13 single nucleotide polymorphisms SNPs, and it submitted numerous patent applications for preliminary disease associations. He also served as the CEO of an advanced materials company that was focused on space-based applications. Additionally, he worked with underperforming venture capital backed companies to assist investors, management, employees and customers to solve significant financial, strategic and execution related problems over the course of two decades. Terry joined McKinsey & Company directly after graduating from the Harvard Business School. He worked out of the firm’s New York and London offices. He left McKinsey to join Exxon Enterprises, Inc. where he pursued a lifelong interest in starting and managing new high-tech companies.
Terry is a former member of the following organizations: Purdue’s Krannert School of Management Alumni Board of Directors; Dean’s Advisory Council at Purdue Honors College; Harvard Business School’s Alumni Board of Directors; HBS MBA Class of 1976’s 30th Reunion, 35th Reunion, 40th Reunion and 45th Reunion where he served as Co-Chairman, Social Committee; Dana-Farber Cancer Center’s Visiting Committee for the Lank Center for Genitourinary Oncology; and Maine Cancer Consortium’s Board of Directors where he served as Chairman and CEO.
During non-reunion years, Terry serves as the Class Secretary and Co-Chair of Social Activities for the Harvard Business School MBA Class of 1976.